Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

LENZ Therapeutics (LENZ) FCF Margin (2025)

LENZ Therapeutics (LENZ) has disclosed FCF Margin for 1 consecutive years, with 2082.05% as the latest value for Q4 2025.

  • Quarterly FCF Margin changed N/A to 2082.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 366.71% through Dec 2025, changed N/A year-over-year, with the annual reading at 366.71% for FY2025, N/A changed from the prior year.
  • FCF Margin for Q4 2025 was 2082.05% at LENZ Therapeutics, down from 72.22% in the prior quarter.
  • The five-year high for FCF Margin was 72.22% in Q3 2025, with the low at 2082.05% in Q4 2025.